DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. - Wikidata - awgldk - TriplyDB

DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

http://www.wikidata.org/entity/Q39923092

about

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling Epigenetic modulators as therapeutic targets in prostate cancer piRNA involvement in genome stability and human cancer L1 retrotransposons, cancer stem cells and oncogenesis Prostate cancer epigenetics and its clinical implications Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)DNA hypomethylation in cancer cells.Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.Particle swarm optimization with reinforcement learning for the prediction of CpG islands in the human genome.Histone H2A.Z deregulation in prostate cancer. Cause or effect?Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.Oxidative stress and DNA methylation in prostate cancer.Androgen-regulated transcriptional control of sialyltransferases in prostate cancer cells CpGPAP: CpG island predictor analysis platform.LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis.The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types Epigenetic susceptibility factors for prostate cancer with aging.Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.Comparison of methods for quantification of global DNA methylation in human cells and tissues.Ambient PM exposure and DNA methylation in tumor suppressor genes: a cross-sectional study.Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: a case report A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment.Epigenetics in prostate cancer.DNA Methylation and Flavonoids in Genitourinary Cancers.Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.Role of diet in prostate cancer: the epigenetic link.Anti-inflammatory drugs, antioxidants, and prostate cancer prevention.ksRepo: a generalized platform for computational drug repositioning Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer.Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications.Epigenetic regulation of prostate cancer Cancer-linked satellite 2 DNA hypomethylation does not regulate Sat2 non-coding RNA expression and is initiated by heat shock pathway activation Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in vitro.Cancer/testis antigens and urological malignancies

P2860

Q24289344-902D50D9-4087-452C-93D4-E0163D2286B5 Q26740548-EFAA2401-A403-47AB-9389-AFA760CA9652 Q28071912-920DB3A2-6FD4-4673-B8A6-38AB769609F4 Q28392701-F3424815-4E62-47FE-A7FD-38CFFBCA2453 Q28394080-5A5FBCDE-C7E0-4ADF-AE65-6FA57DB5BA68 Q28829460-48001FDB-9000-4076-8525-59D43EE15713 Q30764223-69B04579-37B7-4945-A5E0-EB1202D54A54 Q33730189-1DC3F405-7C79-4530-810B-8C6F6EBB0D3A Q33752772-89F88224-FB8A-47A2-A718-BBEAE63A30B6 Q33838513-DEE0F838-6368-46AF-8396-43DFF60336EA Q33862334-385B82AA-0786-437C-A861-632E228DD213 Q33931119-6BF9751F-B648-4646-B0BD-F4F5ED12FECB Q33949373-943A54A5-E51A-4ACA-BC99-16A838A6BA28 Q33954660-96EFDD5E-566C-4D1C-B152-AF7FF9A7A6BF Q33962848-01CF1A9E-D439-4FF5-936D-B5799F19280A Q34014559-E32BA79D-BD48-4A61-A54E-C3D64193C5DC Q34021985-FABADBA3-F52D-4891-8023-B76FB7DFBB5E Q34162748-53772C08-B1A9-45C9-86BC-325E237D8736 Q34183365-64846FF3-2513-48C3-9D6A-16BFAAEBBD3E Q34282505-ECA50C5C-167E-4B7A-8E2A-B67E56568095 Q34334489-78B898EF-DD53-4BBA-95C7-A8346349847B Q34433060-BEC0FF73-0888-4406-A0C2-18963603155F Q34541756-51348BB2-E7C4-44DB-B820-07F7B06CC68A Q34632716-C123C6E3-25FA-4B67-9335-2A04C8AD4223 Q35048178-49E57DF3-35A0-4FE6-B145-0E6D6468350F Q35233697-F08A5433-46D5-4CD5-B12C-97FDBB3A091E Q35420723-6BA8ECEF-D8D9-442D-BF17-37186A687D82 Q35581883-40D68E85-E783-46DB-84C8-30C0C9679290 Q35608952-A13EBCD4-9681-4FF7-BAC4-271BC234B474 Q35623184-A42A5E6E-B3BA-4A96-8A57-4295028DD9B4 Q35640316-D47FC818-C42A-493D-B559-6C6BAC33EB9A Q35768176-D587E387-088B-4C90-BB97-E8C17DF07408 Q35775751-FE96E556-E753-4641-BFB6-F71A4E3B17C7 Q35918546-8F3D1B4C-CC9C-4540-840A-315700197048 Q35949278-52DB3D9B-034A-4055-B455-5CEA2BCDE74E Q36001900-2D7FD368-1BA9-4E45-BF90-EE6679B3E70E Q36001910-6AEE2718-362F-40CD-87FC-4DF2B5D69F28 Q36187848-7F925464-4FD6-4A22-A35E-558BAE9E963A Q36281313-DF533C75-22E6-4A2E-AE82-A86830391D69 Q36337004-D9BFDC6A-9580-416E-812F-B26A8BA55D9F

P2860

DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

http://www.wikidata.org/entity/Q39923092

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

DNA hypomethylation arises lat ...... etastatic tumor heterogeneity.

@en

DNA hypomethylation arises lat ...... etastatic tumor heterogeneity.

@nl

type

label

DNA hypomethylation arises lat ...... etastatic tumor heterogeneity.

@en

DNA hypomethylation arises lat ...... etastatic tumor heterogeneity.

@nl

prefLabel

DNA hypomethylation arises lat ...... etastatic tumor heterogeneity.

@en

DNA hypomethylation arises lat ...... etastatic tumor heterogeneity.

@nl

P1433

Q39923092-E2BD9345-E66B-4991-82AA-49817637ECE6

P1476

Q39923092-9D81F646-7BBD-4974-98DE-8F4ED0A10D6F

P2093

Q39923092-17D11C5C-2A30-49A5-BB78-DDFA9108E8EA

Q39923092-22C73CBC-B4D7-42B9-BBBE-F18645FCCF38

Q39923092-286BFE6F-EEF6-42D7-B73A-1011A2663D5D

Q39923092-4A4B8CBA-03D2-443E-B7DA-A9CFB87AA9B7

Q39923092-81DE202D-4C65-4AF6-9979-C97E45CAB0C0

Q39923092-8A4DB318-7EAC-40D8-99DD-723382640B7E

Q39923092-8DE1BEFF-B11A-4499-AACF-DEDF60F1602F

Q39923092-97D0E88F-17F1-4C13-9F0B-4AF762819C94

Q39923092-9E84CF52-B0AE-4BDE-9F93-7DCCAB5C1896

Q39923092-B46781B0-ACDC-41F4-9794-98E12F343A50

P2860

Q39923092-03B96779-6BCC-4B92-8135-090BFB0345E7

Q39923092-08B5643C-511F-4ECA-9A0A-2E6DA89039C4

Q39923092-09782EF4-916E-47E4-A39A-C740B11C0AD5

Q39923092-13E21156-DF14-413D-9ECD-691132FAA62B

Q39923092-14C2F7B7-CEFF-40A5-B6A5-D371B53E0267

Q39923092-15FFFC03-38F8-4B66-A20E-DA39D3BA9D00

Q39923092-265174A5-A1FA-43B2-A4CB-CD1A0801B70E

Q39923092-29E9BB32-18BB-4965-8865-5E1E4BA4A479

Q39923092-2CF7F201-2C05-416A-A3EC-937CEDF5BD4E

Q39923092-32F22DF2-C3AA-4E3C-9D63-A05C2183C32D

P304

Q39923092-F0A3517D-BC12-40A4-BD38-F5DE7484B6A4

P31

Q39923092-891954A1-0A0A-42C2-8DAA-21B28ABD29F0

P356

Q39923092-E51970B0-BD58-4CBE-B655-2C5E0DB1AAD1

P407

Q39923092-FFF18A23-F522-4F96-8BF3-415C9A47515D

P433

Q39923092-43913EAE-6CE3-4722-B147-CE9036466FBE

P478

Q39923092-34C7546B-ECDF-4B38-8493-4F34ABA15E1D

P50

Q39923092-0F629961-799E-4B83-BB3D-C67030A39BB6

Q39923092-CF98A260-4991-4E93-83ED-F0FAEADA5F5E

Q39923092-F46D31A4-B481-48F0-904D-5B05DC0E6253

P577

Q39923092-91913E70-187D-4F2D-808D-0F47A6A2215C

P5875

Q39923092-4ADED2D8-36E5-4E59-9D15-A3F864AAA3F7

P698

Q39923092-DBE3B873-F168-4E5A-91CB-09C6ECD7580F

P932

Q39923092-DC773E26-F23E-4325-995C-DCC25C61DA9B

P356

0008-5472.CAN-07-6088

P1433

Cancer Research

P1476

DNA hypomethylation arises lat ...... metastatic tumor heterogeneity

@en

P2093

Angelo M De Marzo

http://www.w3.org/2001/XMLSchema#string

G Steven Bova

http://www.w3.org/2001/XMLSchema#string

James Morgan

http://www.w3.org/2001/XMLSchema#string

Jessica Hicks

http://www.w3.org/2001/XMLSchema#string

Michael C Haffner

http://www.w3.org/2001/XMLSchema#string

Rafael A Irizarry

http://www.w3.org/2001/XMLSchema#string

Srinivasan Yegnasubramanian

http://www.w3.org/2001/XMLSchema#string

Theodore L DeWeese

http://www.w3.org/2001/XMLSchema#string

William B Isaacs

http://www.w3.org/2001/XMLSchema#string

William G Nelson

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

The Sequence of the Human Genome

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

Intra-individual change over time in DNA methylation with familial clustering

Molecular archeology of L1 insertions in the human genome.

Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation

CpG-rich islands and the function of DNA methylation

A gene hypermethylation profile of human cancer

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

ONCOMINE: a cancer microarray database and integrated data-mining platform

P304

8954-8967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-07-6088

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23441716

http://www.w3.org/2001/XMLSchema#string

P698

18974140

http://www.w3.org/2001/XMLSchema#string

P932

2577392

http://www.w3.org/2001/XMLSchema#string